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Stomatococctrr mtrcilaginorrrs is a normal inhabitant of the 
mouth, throat and upper respiratory tract. It is a Grani- 
positive coccus closely related to the genus Rothia [l]. 
Since the first case in 1978, its involvement has been 
reported in an increasing spectrum of infections, 
exclusively among immunocompromised patients. We 
report a case of pneumonia in an AIDS patient and 
review the 69 published cases of infection due to this 
pathogen. 
A 43-year-old man was admitted for subacute 
dyspnea. He was a heavy smoker. A positive serology 
for HIV had been discovered in 1989. He had genital 
tuberculosis in 1990, pneumocystis pneumonia in 1995 
(with cutaneous allergy to co-trimoxazole), and cerebral 
toxoplasmosis in June 1996. His medications were penta- 
midine aerosol, pyrimethamine, clindamycin, indinavir, 
stavudine, and lamivudine. 
In December 1996, the patient began to complain 
of mild dyspnea, which became worse in the first days 
of 1997, accompanied by a productive cough. The 
patient was admitted in January. O n  examination, he 
was polypneic (respiration rate: 40/min) with orthopnea, 
audible bronchospasm with bilateral symmetric sibilants, 
ronchi, and some crackles in the two bases. His tempera- 
ture was 37.2OC, his pulse was 100/min, and his blood 
pressure was 130/70 mmHg. The chest X-ray showed 
a sequellar reticular pattern in the middle lobe. The 
arterial blood partial pressure of oxygen was 70 mmHg, 
the carbon dioxide level was 30.5 mmHg, p H  7.4, 
and the bicarbonate level was 21 mmol/L. The white 
cell count was 6300/mm3, the neutrophil count was 
-1200/mm3, the CD4’ lymphocyte count was 5O/mm3 
(6%), the platelet count was 210 OOO/mm3, and the 
hemoglobin level was 13.3 g/dL. The C-reactive 
protein level was 212 mg/L. The other laboratory 
values were normal. O n  admission, pneumocystis 
pneumonia due to prophylaxis failure was suspected. 
Intravenous trimethoprim-sulfamethoxazole and rnethyl- 
prednisolone were started with aerosolized salbutamol. 
As the patient’s condition did not improve, a fibro- 
bronchoscopic examination was performed on the 
fourth day. It showed purulent secretions from the 
entire bronchial tract. The bronchoalveolar lavage 
showed 8.1 x lo6 cells/mL with 85% neutrophils, no 
acid-fast bacilli, no pneumocystis, and negative im- 
munofluorescence for Legionella. Gram-stained smears 
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Table 1 Infections due to Stornatococrus muciluLqinorris: clinical presrntation. main underlying diseases and predisposing 
conditions 14-14] 
Nunibcr 
of cases 
Fatal 
outcome 
Bactereiniac 40 
Meningitis 8 
Endocarditis 7 
Pneumonias 7 
 miscellaneous^' 7 
Total 60 
Underlying disease Prcdisposing conditions 
Leukemia HMT Solid tumors Others Neutropenia CVC Mucitis Others 
17 5 9 AIDS 2 24 23 11 IVIIU 2 
Diabetes 2 Catheter- Dental 
related 7 surgery 2 
Heart valvular IVDU 4 
abnormalities 4 
Valvular prosthesir 4 
.. 1 1 AIDS1 4 4 2 
21 10 11 36 31 15 
3 3 1 7 6 1 -J 
? 
1 Dialysis 2 1 1 
BMT, bone marrow transplantation; CVC, central venous catheter; IVDU, intravenous drug user. 
osteoniyrliti,, cholangitis. The last two cases occurred without imniunodepresion 19.1 01. 
Two chronic anibulatory peritoneal dialysis peritonits, empyema, cellulitis around a Broviac catheter, nosocomial endophthalinitis. 
showed numerous Gram-positive cocci in clumps. 
After bronchoscopic examination, trimethoprim- 
sulfamethoxazole was enipirically replaced by amoxy- 
cillin plus clavulanic acid (3 g/day). The patient’s 
condition improved quickly in 1 days. S. mucilaginosns 
grew in pure culture (lo5 CFU/mL) in the endo- 
tracheal aspirates and in the bronchoalveolar lavage. It 
was characterized by strong adherence to the agar and 
was catalase negative. A high production of slime was 
observed. The antibiograrn (disk diffusion method) 
showed resistance to niacrolides and quinolones, and 
sensitivity to aiiiinoglycosides, rifampicin, fosfomycin, 
and glycopeptides. The penicillin MIC was 8 mg/L 
and that of trimethoprim-sulfaniethoxazole was > 8 
mg/L. All the specimens of blood cultures were 
negative for mycobacteria. Cryptococcal antigenemia 
results were negative and so were the results of the 
search for cytomegalovirus. The serologic tests for 
chlamydiae, Alycoplasrna, Lgiorzrlla, rickettsiae, influenza 
virus, parainfluenza virus, syncytial respiratory virus 
and adenovirus were negative. 
The clinical spectrum of S. nimcilaggirzosus infections 
is expanding. Sixty-nine cases (Table 1) have been 
recorded with 31 in children. Fifty-eight per cent are 
bacteremias. Almost all cases occur in conjunction with 
a severe underlying disease as shown in Table 1,  mainly 
leukemia, bone marrow transplantation, and solid 
cancers. Three main predisposing conditions are found: 
neutropenia due to drug toxicity (defined as less than 
1000/nin13 neutrophils), central venous catheter, and 
riiucosal ulcerations. 
These predisposing factors are a consequence of 
the properties of Stotnatococci~s. Since this organism 
belongs to the oral flora, oral ulcerations are a portal 
of entry, especially if neutropenia develops. This is 
in agreement with previous studies which recorded 
an increasing incidence of Gram-positive cocci in 
bacteremias among hematologic patients treated with 
aplastic cheniotherapies 121. The strong adhesive qualities 
of Stomatococcus [3] may predispose its engraftrnent 
on defective heart valves or prostheses. One  hypo- 
thesis for the origin of Stornatococcus in endocarditis is 
the tendency of drug users to lick the needle, so as 
not to lose any drug, or to stick theniselves in the 
mouth. 
Four S. rnncilagiriosus infections have been reported 
in AIDS patients: two bacteremias [4,5] and two 
pneumonias [5,6]. We report a third case of pneu- 
monia. In the three cases of pneumonia in AIDS 
patients, Stomatococcus was isolated from the lungs 
(bronchoalveolar lavage). In imniunocompromised 
patients, with impaired bronchial immunity, Stomato- 
coccus, found in bronchial secretions [3],  can easily 
invade the parenchyma. Moreover, AIDS patients 
often have oral ulcerations. In all AIDS patients, 
CD1+ lymphocyte counts were lower than 100/mni3. 
Although rare, Stomatococccus has become an oppor- 
tunistic pathogen in HIV-positive and other immuno- 
compromised patients. 
P-Lactaiiis were used in 43 of the reported cases 
and vancomycin in 35 cases. Strains with diminished 
susceptibility to penicillin (from 0.35 to 1 mg/L) have 
sometimes been isolated 171. Moreover, the strains 
isolated in AIDS patients who had previously received 
co-trimoxazole as prophylaxis for pneumocystis have 
diminished susceptibility to this antibiotic, although 
Stomatococcus is usually sensitive [1,6]. Initial antibiotic 
therapy with glycopeptides is the most rational choice, 
but therapy should be switched to p-lactams if results 
of in vitro testing reveal a sensitive organism. 
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Coagulase-negative staphylococci differ phenotypically 
from Staphylococcus aureus by lacking the ability to form 
some extracellular products and cell wall-associated 
proteins [l]. In routine clinical microbiology the 
coagulase test-tube reaction has been used as the main 
species characteristic of S. auretcs [l], as has DNase 
formation in food microbiology [2]. Although less 
sensitive and less specific than coagulase formation [3],  
the demonstration of clumping factor is often used in 
routine clinical microbiology. The clumping factor of 
S.  uureus is a cell wall-associated protein which reacts 
with fibrinogen monomers, thus leading to aggregation 
of S. arireiis cells [4]. The recent emergence of epidemic 
methicillin-resistant S.  aureus (MRSA) lacking this 
capability [5] has rendered tests based only on the 
demonstration of protein agglutination unreliable [6]. 
Therefore, recently developed test kits have included 
the use of antibodies against cell wall-associated macro- 
molecules, and IgG specific for S. arireus protein A [7]. 
This communication reports on the sensitivity and 
specificity of the Dry Spot Staphytect Plus test (Oxoid, 
Basingstoke, UK) and three other agglutination tests for 
speciating staphylococcal species, especially S.  aureus 
including methicillin-resistant isolates. 
For methicillin-sensitive S. aureus (MSSA, tz= 130), 
strains belonging to the major clonal group of this 
species as deduced from genomic DNA fragment 
patterns [8] were tested. For MRSA (n=8O), five 
isolates from each of six MRSA epidemics with an 
inter-regional dissemination in Germany [9] were 
